Clinical trial Recruiting at 1 site Observational Ages 18 to 120

Using breath analysis for quick diagnosis of respiratory diseases

Official title: Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections

Run by Oregon Health and Science University · NCT06775106 · Data updated 2026-11-12

This study is testing a new way to quickly diagnose respiratory diseases by analyzing the breath of patients on ventilators to see if it can help detect problems earlier.

Quick facts

Study typeObservational
Ages18 Years to 120 Years
SexAll
Enrollment100 (estimated)
SponsorOregon Health and Science University
Academic / other
Locations1 site (Portland, Oregon)
StatusRecruiting
StartedNovember 30, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJanuary 14, 2025
Trial IDNCT06775106 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are non-COVID-19 adult patients over 18 years old who are on ventilatory support in the ICU.

Probably not a fit

Patients experiencing severe respiratory distress or hemodynamic instability may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to validate a novel technique using mass spectrometry to analyze exhaled breath from non-COVID ICU patients on ventilation. The study will employ Orbitrap and MALDI mass spectrometry to capture and analyze proteins in breath samples, correlating these findings with existing clinical data to enhance early detection of pulmonary diseases. By focusing on ventilator-dependent patients, the study seeks to establish a rapid diagnostic tool that could be utilized in non-ICU settings for respiratory pathogen detection.

Why it matters

Potential benefit: If successful, this technique could lead to faster and more accurate diagnoses of respiratory diseases, improving patient outcomes.

How similar studies have gone: While the approach is innovative, similar studies using breath analysis for disease detection have shown promise, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Non-COVID-19 adult consented patients (\>18yo) on ventilatory support in the ICU at OHSU

Exclusion Criteria:

* Patients with "severe respiratory distress" as defined by arterial pO2 of \<60 mmHg on maximal FiO2 \& optimal ventilator settings
* Patient with severe hemodynamic instability as defined by (a) receiving IV infusion of 2 or more pressors or inotropic medications (Levophed, vasopressin, phenylephrine, or epinephrine) \& (b) MAP of \<60 mmHg or SB \<80 mmHg

Where it's running

  • Oregon Health and Science University
    Portland, Oregon, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.